Company / Working Capital per Share
ADMA Biologics, Inc. Working Capital per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$1.68
FY2025
5-year range
$0.93 / $1.70
FY2021-FY2025
Trend
+37.5%
vs FY2024
Sector context
#162 of 210
Health Care
What the data says
ADMA Biologics, Inc.'s working capital per share of $1.68 is lower than 77% of companies in the Health Care sector (FY2025). Working Capital per Share has fluctuated over the past 10 years, ranging from $0.93 in FY2023 to $4.17 in FY2017.
Based on SEC 10-K filings.
1.68 in FY2025 with a 5-year CAGR of -5.7%.
Improved from $0.93 to $1.68 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- +12.4%
- 5-Year CAGR
- -5.7%
- 10-Year CAGR
- -
Sector benchmark
Bottom 23% in Health CareTop 77% of 210This company $1.68 Sector average $118.60
▼
-98.6% below sector average
Key checks
Key Insights
- In FY2025, working capital per share increased 37.5% year-over-year.
- Ranks #162 out of 210 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2017.
- Lowest working capital per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score 3.37 (safe zone, above 2.9 threshold)
- Strong profit margin: 46.4%
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.68 | +37.5% |
| FY2024 | $1.22 | +30.6% |
| FY2023 | $0.93 | -20.9% |
| FY2022 | $1.18 | -30.6% |
| FY2021 | $1.70 | -24.6% |
| FY2020 | $2.26 | +45.6% |
| FY2019 | $1.55 | +63.0% |
| FY2018 | $0.95 | -77.2% |
| FY2017 | $4.17 | +328.1% |
| FY2016 | $0.97 | -47.0% |
As of FY2025 · SEC 10-K · Updated Jul 1, 2026